Europe Drug Eluting Stent Market Size & Outlook, 2023-2030

The drug eluting stent market in Europe is expected to reach a projected revenue of US$ 3,757.8 million by 2030. A compound annual growth rate of 8.4% is expected of Europe drug eluting stent market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,139.7
Forecast, 2030 (US$M)
$3,757.8
CAGR, 2024 - 2030
8.4%
Report Coverage
Europe

Europe drug eluting stent market highlights

  • The Europe drug eluting stent market generated a revenue of USD 2,139.7 million in 2023.
  • The market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
  • In terms of segment, polymer-based coating was the largest revenue generating type of coating in 2023.
  • Polymer-free Coating is the most lucrative type of coating segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 2,139.7 million
Market revenue in 2030USD 3,757.8 million
Growth rate8.4% (CAGR from 2023 to 2030)
Largest segmentPolymer-based coating
Fastest growing segmentPolymer-free Coating
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPolymer-based Coating, Polymer-free Coating
Key market players worldwideAbbott Laboratories, Boston Scientific Corp, Terumo Corp, Medtronic PLC, Lepu Medical, Biosensors, Cook Medical, B. Braun, BIOTRONIK


Other key industry trends

  • In terms of revenue, Europe region accounted for 27.6% of the global drug eluting stent market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,215.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Eluting Stent Market Companies

Name Profile # Employees HQ Website

Europe drug eluting stent market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug eluting stent market will help companies and investors design strategic landscapes.


Polymer-based coating was the largest segment with a revenue share of 83.41% in 2023. Horizon Databook has segmented the Europe drug eluting stent market based on polymer-based coating, polymer-free coating covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe drug eluting stent market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe drug eluting stent market databook

  • Our clientele includes a mix of drug eluting stent market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe drug eluting stent market , including forecasts for subscribers. This continent databook contains high-level insights into Europe drug eluting stent market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe drug eluting stent market size, by country, 2018-2030 (US$M)

Europe Drug Eluting Stent Market Outlook Share, 2023 & 2030 (US$M)

Europe drug eluting stent market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more